Search

Your search keyword '"Brugger W"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Brugger W" Remove constraint Author: "Brugger W" Publisher elsevier ltd Remove constraint Publisher: elsevier ltd
25 results on '"Brugger W"'

Search Results

1. Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer

9. 833P - AZD8186, a potent and selective inhibitor of PI3Kβ/δ, as monotherapy and in combination with abiraterone acetate plus prednisone (AAP), in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC)

10. 37 - AZD8186 study 1: Phase I study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary anti-tumour activity of AZD8186 in patients with advanced castration-resistant prostate cancer (CRPC), squamous non-small cell lung cancer, triple negative breast cancer and with PTEN-deficient/mutated or PIK3CB mutated/amplified malignancies, as monotherapy and in combination with vistusertib (AZD2014) or abiraterone acetate

Catalog

Books, media, physical & digital resources